What if COVID-19 affects the child: which weapons and how to use them

被引:3
作者
Anedda, L. [1 ]
Bianchini, L. [1 ]
Cuzzolin, L. [2 ]
Finco, G. [3 ]
Fanos, V [4 ,5 ]
Marcialis, M. A. [4 ]
机构
[1] Univ Cagliari, Sch Pediat, Cagliari, Italy
[2] Univ Verona, Dept Diagnost & Publ Hlth, Verona, Italy
[3] Univ Cagliari, Dept Med Sci & Publ Hlth, Intens Care Unit, Cagliari, Italy
[4] AOU Cagliari, Neonatal Intens Care Unit, Cagliari, Italy
[5] Univ Cagliari, Dept Surg, Cagliari, Italy
关键词
COVID-19; 2019-nCov; SARS-CoV-2; Treatment; Pediatrics; Review; CORONAVIRUS DISEASE; RIBAVIRIN; PREVENTION; INHIBITORS; INFECTION; DIAGNOSIS;
D O I
10.26355/eurrev_202104_25744
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Since the reports in Wuhan (China), in December 2019, of the first cluster of cases of pneumonia caused by the new Coronavirus called 2019-nCoV or SARS-CoV-2, there has been a pandemic spread of the infection. By now, we have no specific therapy to counteract this emergency. The latest epidemiological data suggest that children are just as likely as adults to get infected by the virus. Most of them show mild clinical pictures or are completely asymptomatic, but there is an increased risk for severe disease in infancy (<12 months of age) and in children with underlying medical conditions. In this article, research achievements on the treatment of pediatric SARS-CoV-2 infection are examined.
引用
收藏
页码:3325 / 3337
页数:13
相关论文
共 69 条
  • [1] COVID 19 infection: Pediatric perspectives
    Adeyinka, Adebayo
    Bailey, Keneisha
    Pierre, Louisdon
    Kondamudi, Noah
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2021, 2 (01)
  • [2] Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
    Agostini, Maria L.
    Andres, Erica L.
    Sims, Amy C.
    Graham, Rachel L.
    Sheahan, Timothy P.
    Lu, Xiaotao
    Smith, Everett Clinton
    Case, James Brett
    Feng, Joy Y.
    Jordan, Robert
    Ray, Adrian S.
    Cihlar, Tomas
    Siegel, Dustin
    Mackman, Richard L.
    Clarke, Michael O.
    Baric, Ralph S.
    Denison, Mark R.
    [J]. MBIO, 2018, 9 (02):
  • [3] Optimizing the Use of Hydroxychloroquine in the Management of COVID-19 Given Its Pharmacological Profile
    Ali, Ahmed S.
    Abdel-Rahman, Mahran S.
    Almalikil, Riyadh S.
    Mohamed, Abir S.
    Alfaifi, Khalid A.
    El Fadil, Abdelbabgi
    EI-Shitany, Nagla A.
    Alkreathy, Huda M.
    [J]. JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2020, 32 (08) : 29 - 43
  • [4] [Anonymous], 2020, SFCHRONICLE
  • [5] Different interferons: pharmacology, pharmacokinetics, proposed mechanisms, safety and side effects
    Arnaud, P
    [J]. REVUE DE MEDECINE INTERNE, 2002, 23 : 449S - 458S
  • [6] Covid-19-The Search for Effective Therapy
    Baden, Lindsey R.
    Rubin, Eric J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (19) : 1851 - 1852
  • [7] Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020
    Bialek, Stephanie
    Gierke, Ryan
    Hughes, Michelle
    McNamara, Lucy A.
    Pilishvili, Tamara
    Skoff, Tami
    [J]. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (14): : 422 - 426
  • [8] A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
    Boulware, David R.
    Pullen, Matthew F.
    Bangdiwala, Ananta S.
    Pastick, Katelyn A.
    Lofgren, Sarah M.
    Okafor, Elizabeth C.
    Skipper, Caleb P.
    Nascene, Alanna A.
    Nicol, Melanie R.
    Abassi, Mahsa
    Engen, Nicole W.
    Cheng, Matthew P.
    LaBar, Derek
    Lother, Sylvain A.
    MacKenzie, Lauren J.
    Drobot, Glen
    Marten, Nicole
    Zarychanski, Ryan
    Kelly, Lauren E.
    Schwartz, Ilan S.
    McDonald, Emily G.
    Rajasingham, Radha
    Lee, Todd C.
    Hullsiek, Kathy H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (06) : 517 - 525
  • [9] Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI [10.1056/NEJMoa2001282, 10.1056/NEJMc2008043]
  • [10] High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
    Cao, Wei
    Liu, Xiaosheng
    Bai, Tao
    Fan, Hongwei
    Hong, Ke
    Song, Hui
    Han, Yang
    Lin, Ling
    Ruan, Lianguo
    Li, Taisheng
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (03): : 1 - 6